OR02-4
Impact of the Shock Team on Institutional use of VA-ECMO for Cardiogenic Shock
Presenter
Miguel Alvarez Villela, MD, Northwell Health Lenox Hill Hospital, Lenox Hill, NY
Rebecca Smoller, DO1, Fouad Sakr2, Moein Bayat Mokhtari, MD2, Marcy Miller, BS2, Kayla Floyd2, Zachary Kon1, Hayley Chestnut1, Varinder P Singh, MD2, Michael C. Kim, MD, FSCAI2, Sabrivinoth Rangasamy1, Kush Dholakia1, Jacob Scheinerman1, Sirish Vullaganti1, Chad Kliger, M.D., FSCAI2, Arber Kodra, MD2 and Miguel Alvarez Villela, MD1, (1)Northwell Health Lenox Hill Hospital, Lenox Hill, NY, (2)Northwell Health Lenox Hill Hospital, New York, NY
Keywords: Cardiogenic Shock and Hemodynamic Support
Background
Shock Teams (ST) have been associated with higher use of advanced mechanical circulatory support in cardiogenic shock (CS) patients. The impact of the ST on hospital VA-ECMO use for CS is undescribed. Methods
We performed a retrospective review of all patients treated at our institution with VA-ECMO for CS in the 18 months before (pre-ST era: January 2021-June 2022) and after (ST era: July 2022- December 2023) the creation of a local ST. Statistics are descriptive. Results
Thirty-three patients received VA-ECMO for various CS etiologies during the study period. During the ST era there was a 130% increase in institutional VA-ECMO volume with lower median patient age and similar sex distribution. Peripheral cannulations and cannulations by interventional cardiology increased after the ST creation. ECPR and the use of atrial septostomy during ECMO were new adoptions in the ST era. Survival to discharge was unchanged. Conclusions
The creation of a ST led to important changes in patterns of ECMO use, with a large increase institutional volume and acceptable hospital survival. 
